Browsing: 2024 – November

The different risk exposures and risk appetites of insurance companies mean that reinsurance is used in a number of ways as there is not a ‘one size fits all’ offering.

While ageing is fundamentally a physiological phenomenon, numerous factors significantly influence the rate at which this process occurs. Certain factors can accelerate the ageing process, while some have the potential to decelerate it, influencing the rate of physiological decline.

Dr. Rahul Nawander, Medical Director at Fasano Underwriting, offers his views on what is impacting LEs generally from a medical perspective.

There are few options available to investors that want exposure to longevity risk in Canada, but a new idea could expand this currently limited market.

Pension consulting firm K3 Advisory has led the completion of a £2m full scheme buy-in transaction with an unnamed sponsor in the mechanical and electrical industry with Legal & General.

The Atradius UK Pension Scheme has concluded a £190m bulk purchase annuity buy-in transaction with PIC that secures the pensions of 361 current pensioners and dependents, 344 deferred members and 66 active members.

Applications for universal life insurance, the main type of insurance seen in the life settlement market, continued their recent decline in October.

New report suggests overall growth in the opportunity in life settlements is outpacing the investment in the asset class.

£70m buy-in transaction will secure the benefits of all uninsured scheme members, covering approximately 490 deferred members and 400 pensioner members.

£7m deal was completed in March and insures the benefits of 24 pensioners and 15 deferred members.